Roja Pondicherry-Harish, MD
Interventional Cardiology · Gainesville, FLNPI 1669764437
Payments from drug & device makers
Across 288 payments — averaging $56.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Abiomed$3K
- Penumbra, Inc.$1K
- Medtronic$1K
- Boston Scientific$881
- Cook Medical LLC$876
- plus $4K from 23 others
What the payments were for
- Consulting fees$1,3138%
- Travel & lodging$4,72129%
- Food & beverage$10,27463%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 31 | $5,044 |
| Abiomed | 15 | $2,707 |
| Penumbra, Inc. | 10 | $1,388 |
| Medtronic(2 entities) | 15 | $1,224 |
| Boston Scientific | 11 | $881 |
| Cook Medical LLC | 47 | $876 |
| E.r. Squibb & Sons, L.L.C. | 26 | $547 |
| Amgen | 24 | $503 |
| Edwards Lifesciences | 5 | $421 |
| Bard Peripheral Vascular, Inc. | 4 | $301 |
| Angiodynamics, Inc. | 21 | $285 |
| Recor Medical Inc | 3 | $284 |
| Pfizer | 17 | $280 |
| Verge Medical, Inc. | 1 | $247 |
| Johnson & Johnson | 9 | $245 |
| Boehringer Ingelheim | 3 | $144 |
| Novartis | 7 | $134 |
| Acist Medical Systems, Inc. | 5 | $129 |
| Shockwave Medical, Inc | 1 | $125 |
| Cardiovascular Systems Inc. | 7 | $101 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $101 |
| AstraZeneca | 6 | $97 |
| Cvrx, Inc. | 4 | $96 |
| Lexicon Pharmaceuticals, Inc. | 3 | $55 |
| Merck | 3 | $49 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $18 |
| Teleflex LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$2,349
- OPTIS$1,795
- DRAGONFLY OPSTAR$1,313
- Indigo$1,096
- COREVALVE EVOLUT R$732
- MitraClip System$720
- OSTIAL Flash System$247
- Edwards SAPIEN 3 Transcatheter Heart Valve$236
- Optis Coronary Imaging System$209
- GENERAL - THERAPIES$151
- Paradise Ultrasound Renal Denervation System$149
- Rotarex$141
- GENERAL ATHERECTOMY$139
- NAVITOR$137
- Cook$135
- RESOLUTE ONYX$134
- ONYX FRONTIER$131
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$129
- WATCHMAN FLX$125
- RotarexS 6 F x 135 cm$125
How this compares
$16,350 in reported general payments places this provider in the 60th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 280 | $262,706 |
| Repatha SureclickEvolocumab | 124 | $100,483 |
| JardianceEmpagliflozin | 79 | $93,819 |
| XareltoRivaroxaban | 77 | $91,911 |
| EntrestoSacubitril/Valsartan | 86 | $80,652 |
| Praluent PenAlirocumab | 28 | $17,230 |
| VascepaIcosapent Ethyl | 12 | $7,159 |
| ClopidogrelClopidogrel Bisulfate | 368 | $3,987 |
| Atorvastatin Calcium | 444 | $3,917 |
| Metoprolol Succinate | 213 | $2,989 |
| Ezetimibe | 67 | $2,077 |
| Valsartan | 82 | $1,933 |
| Clonidine | 14 | $1,761 |
| Ranolazine ErRanolazine | 12 | $1,739 |
| Prasugrel Hcl | 24 | $1,701 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $280 | $262,706280 claims |
| Boehringer IngelheimJardiance | $144 | $93,81979 claims |
| Johnson & JohnsonXarelto | $245 | $91,91177 claims |
| NovartisEntresto | $134 | $80,65286 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Gainesville
- Arthur LeeGainesville$2M
- Amit BadiyeGainesville$449K
- Matheen KhuddusGainesville$423K
- R AndersonGainesville$238K
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.